Taysha Gene Therapies, Inc. · NASDAQ:TSHA

Octagon Capital Advisors LP reported a 5.10% stake in Taysha Gene Therapies, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 5, 2025

Octagon Capital Advisors LP reported a 5.10% stake in Taysha Gene Therapies, Inc., 10,450,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G).

Stake
5.10%
Shares
10,450,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Octagon Capital Advisors LP5.10%10,450,000
Octagon Investments Master Fund5.10%10,450,000
Ting Jia5.10%10,450,000

Source

View original at SEC

Related